Canterbury, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of gene therapies designed for neurological disorder treatment. EpilepsyGTX is based in Canterbury, United Kingdom and was founded in 2021. Its last reported valuation was $47.2 million in Dec 2025. It has raised $47.5 million.
Last reported valuation
$47.2M
Oct 2026
Priced at
—
Total raised
$47.5M
Last round
—
Cap table — not yet on record
EpilepsyGTX's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of EpilepsyGTX with a free account
·Watch EpilepsyGTX: the Monday email on marks, rounds and moves
